Welcome to NQMC. Skip directly to: Search Box, Navigation, Content.


Brief Summary


TITLE

Coronary heart disease: the percentage of patients with newly diagnosed angina (diagnosed after 1 April 2003) who are referred for exercise testing and/or specialist assessment.

SOURCE(S)

  • British Medical Association (BMA). Quality and outcomes framework guidance for GMS contract 2008/09. London (UK): British Medical Association, National Health Service Confederation; 2008 Apr. 148 p.

Measure Domain

PRIMARY MEASURE DOMAIN

SECONDARY MEASURE DOMAIN

Does not apply to this measure

Brief Abstract

DESCRIPTION

This measure is used to assess the percentage of patients with newly diagnosed angina (diagnosed after 1 April 2003) who are referred for exercise testing and/or specialist assessment.

RATIONALE

Coronary heart disease (CHD) is the single commonest cause of premature death in the United Kingdom (UK). The research evidence relating to the management of CHD is well established and if implemented can reduce the risk of death from CHD and improve the quality of life for patients. This measure is one of ten Secondary Prevention of Coronary Heart Disease (CHD) measures. The "Secondary Prevention of Coronary Heart Disease (CHD)" indicator set focuses on the management of patients with established CHD consistent with clinical priorities in the four nations.

The Quality and Outcomes Framework (QOF) does not specify how the diagnosis of angina is made or confirmed. This will vary from patient to patient, e.g., clinical history, response to medication, results of investigations, hospital letters, etc.

In general, angina is a clinical diagnosis. Patients with suspected angina should have a 12 lead electrocardiogram (ECG) performed. The presence of an abnormal ECG supports a clinical diagnosis of CHD.

An abnormal ECG also identifies a patient at higher risk of suffering new cardiac events in the subsequent year. However, a normal ECG does not exclude coronary artery disease. Refer to the Scottish Intercollegiate Guideline Network (SIGN) guideline, "Management of stable angina" (SIGN Publication No. 96, February 2007) for further information.

As an additional assessment (rarely for diagnosis), patients with newly diagnosed angina should be referred for exercise-testing or myocardial perfusion scanning.

The aim of further investigation is to provide diagnostic and prognostic information and to identify patients who may benefit from further intervention.

Exercise tolerance testing (ETT) has been shown to be of value in assessing prognosis of patients with coronary artery disease. An ETT is also helpful in patients at high risk of CHD, where a positive test can provide useful prognostic information.

Patients should not be referred for an ETT if:

  • They are on maximal medical treatment and still have angina symptoms
  • The diagnosis of CHD is unlikely (these patients should be referred to a cardiologist)
  • They are physically incapable of performing the test
  • They have clinical features suggestive of aortic stenosis or cardiomyopathy
  • The results of stress testing would not affect management

Refer to the SIGN guideline, 96 (2007) for further information.

Specialist Referral:

An alternative to referral for exercise-testing is referral to a specialist for evaluation. Referral would normally be to a cardiologist, general physician or general practitioner (GP) with a special interest.

PRIMARY CLINICAL COMPONENT

Coronary heart disease; exercise testing; referral for specialist assessment

DENOMINATOR DESCRIPTION

Patients with newly diagnosed angina (diagnosed after 1 April 2003)

NUMERATOR DESCRIPTION

Number of patients from the denominator who are referred for exercise testing and/or specialist assessment*

*Note: For the purposes of the Quality Outcomes Framework (QOF) an appropriate referral being undertaken between three months before and twelve months after a diagnosis of angina has been made would be considered as having met the requirements of this indicator.

DATA SOURCE

Medical record
Registry data

Identifying Information

ORIGINAL TITLE

CHD 2. The percentage of patients with newly diagnosed angina (diagnosed after 1 April 2003) who are referred for exercise testing and/or specialist assessment.

MEASURE COLLECTION

MEASURE SET NAME

DEVELOPER

British Medical Association
National Health System (NHS) Confederation

FUNDING SOURCE(S)

The expert panel who developed the indicators are entirely funded by a grant from the English Department of Health.

COMPOSITION OF THE GROUP THAT DEVELOPED THE MEASURE

The main indicator development group is based in the National Primary Care Research and Development Centre in the University of Manchester. They are: Professor Helen Lester, NPCRDC, MB, BCH, MD; Dr. Stephen Campbell, NPCRDC, PhD; Dr. Umesh Chauhan, NPCRDC, MB, BS, PhD.

Others involved in the development of individual indicators are: Professor Richard Hobbs, Dr. Richard McManus, Professor Jonathan Mant, Dr. Graham Martin, Professor Richard Baker, Dr. Keri Thomas, Professor Tony Kendrick, Professor Brendan Delaney, Professor Simon De Lusignan, Dr. Jonathan Graffy, Dr. Henry Smithson, Professor Sue Wilson, Professor Claire Goodman, Dr. Terry O'Neill, Dr. Philippa Matthews, Dr. Simon Griffin, Professor Eileen Kaner.

FINANCIAL DISCLOSURES/OTHER POTENTIAL CONFLICTS OF INTEREST

None for the main indicator development group.

ENDORSER

National Health Service (NHS)

ADAPTATION

Measure was not adapted from another source.

RELEASE DATE

2004 Apr

REVISION DATE

2008 Apr

MEASURE STATUS

Please note: This measure has been updated. The National Quality Measures Clearinghouse is working to update this summary.

SOURCE(S)

  • British Medical Association (BMA). Quality and outcomes framework guidance for GMS contract 2008/09. London (UK): British Medical Association, National Health Service Confederation; 2008 Apr. 148 p.

MEASURE AVAILABILITY

NQMC STATUS

This NQMC summary was completed by ECRI on September 18, 2006. The information was verified by the measure developer on November 1, 2006. This NQMC summary was updated by ECRI Institute on January 7, 2009. The information was verified by the measure developer on February 9, 2009.

COPYRIGHT STATEMENT

No copyright restrictions apply.

Disclaimer

NQMC DISCLAIMER